This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Dermal Fillers and Botulinum Toxin Market

Market Insights on Dermal Fillers and Botulinum Toxin covering sales outlook, demand forecast & up-to-date key trends

Dermal Fillers and Botulinum Toxin Market By Application (Aesthetic Volume Restoration, Wrinkle Reduction), Product Type (Hyaluronic Acid Based Fillers, Non-Hyaluronic Acid Based Fillers, Botulinum Toxin) & Region - Forecast 2017 - 2027

Celebrity endorsements and consumer market are an important growth driver

Several dermatology association members i.e. service providers and clinics have seen an increased uptake of aesthetic procedures in the year 2016. The American Academy of Facial Plastic and Reconstructive Surgery estimates that more than 80% of surgeons believed a celebrity endorsement played a vital role in the patient being willing to go under the knife and undergo treatment.

The most common procedures are the application of botilinum toxin leading to wrinkle reduction by way of volume restoration. Social and mainstream media have also had an outsized impact on the customer psyche, influencing them to start these treatments early to avoid the onset of ageing or delay it as much as possible.

Customize this Report

Let us know your requirement to get
100% FREE customization

Rising preference for non-invasive surgical procedures across the globe

The demand for minimally invasive cosmetic treatment, a phenomenon seen worldwide, is poised to benefit the Dermal Fillers and Botulinum Toxin Market. Dermatologists prefer to treat skin diseases through less invasive procedures or topical applications in place of surgical methods.

Dermal Fillers and Botulinum Toxin Market Download Report Brochure

The non-surgical procedures that witnessed a dramatic spike in popularity in 2016 were dermal fillers with hyaluronic acid and botulinum toxin. Injectable treatments are chosen because of greater awareness of measurable improvement in procedures and more information dissemination.

Hyaluronic Acid and Botulinum Toxin key in dermal fillers and botulinum toxin market

Botulinum Toxin is the largest segment in the Dermal Fillers and Botulinum Toxin Market by product type and is larger than the other two segments combined. It is expected to push past US$ 5 Bn by the end of the forecast period making it imperative for key stakeholders in the Dermal Fillers and Botulinum Toxin Market to target. However, the Hyaluronic Acid segment is anticipated to witness a high CAGR of 8.5% from 2017-2027, which companies would do well to take note of while devising their Hyaluronic Acid Dermal Fillers and Botulinum Toxin Market strategies.

The Botulinum Toxin segment dominated the global Dermal Fillers and Botulinum Toxin market by product type in terms of revenue in 2017, and this trend is projected to continue throughout the forecast period. Botulinum Toxin is the most attractive segment, with a market attractiveness index of 1.6 over the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Inadequate professional training serious concern in the dermal fillers and botulinum toxin market

The treatments are sometimes administered incorrectly to patients and this can lead to serious complications with extremely adverse side-effects. Fillers are injected around the temple region of the head to even out fine lines and reduce crow’s feet. Patients could experience symptoms such as swelling, fever, and extreme pain within two days, especially if the injection punctures a facial vein during the process of administration.

These unfortunate accidents would need patients to be administered a dose of antibiotics or steroids that have their own additional side-effects. At present, a limited number of medical institutions offer the required advanced training and this is a particular problem in resource-starved, poorer countries in the world where such treatments are more of a luxury only enjoyed by the privileged few.

High cost a major restraint in the dermal fillers and botulinum toxin market

The cost of botolinum toxin treatments is on the higher side and multiple sessions are necessary to achieve the desired results. The surgeon or physician cost alone is approximately half the cost in the case of dermal fillers; and fillers such as HA, PLLA, CaHA last for a maximum period of two years.

Most of them are naturally occurring in the body and they get degraded quickly, which is why multiple sessions are needed, thereby driving up the cost of treatment substantially. Frequent visits to the surgeon or physician is the norm that could potentially stifle the growth prospects of the global Dermal Fillers and Botulinum Toxin Market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Dermal Fillers and Botulinum Toxin Market: Taxonomy

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

Application:

  • Aesthetic Volume Restoration
  • Wrinkle Reduction

Product Type:

  • Hyaluronic Acid Based Fillers
  • Non-Hyaluronic Acid Based Fillers
  • Botulinum Toxin

Frequently Asked Questions

The Dermal Fillers and Botulinum Toxin market is expected to grow at an 6.3% CAGR from 2022 to 2032

By 2022-end, Dermal Fillers and Botulinum Toxin sales are likely to reach US$ 5.9 Billion

Allergan PLC, Ipsen, Merz Pharma GmbH & Co., KGaA, and Daewoong Pharmaceuticals, are some leading Dermal Fillers and Botulinum Toxin market manufacturers.

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. U.S FDA Regulatory Approval for Medical Devices

3.4. Europe Regulatory Approval for Medical Devices

3.5. U.S. FDA approved Dermal Fillers

3.6. U.S. Dermal Fillers and Botulinum Toxin: Key Regulations

4. North America Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2016

4.5.1. Hyaluronic Acid Based Dermal Fillers

4.5.2. Non-hyaluronic Acid Based Dermal Fillers

4.5.3. Botulinum Toxin

4.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2017-2027

4.6.1. Hyaluronic Acid Based Dermal Fillers

4.6.2. Non-hyaluronic Acid Based Dermal Fillers

4.6.3. Botulinum Toxin

4.7. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

4.7.1. Aesthetic Volume Restoration

4.7.2. Wrinkle Reduction

4.8. Market Size (US$ Mn) Forecast, by Application, 2017-2027

4.8.1. Aesthetic Volume Restoration

4.8.2. Wrinkle Reduction

4.9. Drivers and Restraints: Impact Analysis

4.10. Market Attractiveness Analysis

4.10.1. By Country

4.10.2. By Product Type

4.10.3. By Application

4.11. Key Representative Market Presence (Intensity Map)

5. Latin America Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Argentina

5.3.4. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Argentina

5.4.4. Rest of Latin America

5.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2016

5.5.1. Hyaluronic Acid Based Dermal Fillers

5.5.2. Non-hyaluronic Acid Based Dermal Fillers

5.5.3. Botulinum Toxin

5.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2017-2027

5.6.1. Hyaluronic Acid Based Dermal Fillers

5.6.2. Non-hyaluronic Acid Based Dermal Fillers

5.6.3. Botulinum Toxin

5.7. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

5.7.1. Aesthetic Volume Restoration

5.7.2. Wrinkle Reduction

5.8. Market Size (US$ Mn) Forecast, by Application, 2017-2027

5.8.1. Aesthetic Volume Restoration

5.8.2. Wrinkle Reduction

5.9. Drivers and Restraints: Impact Analysis

5.10. Market Attractiveness Analysis

5.10.1. By Country

5.10.2. By Product Type

5.10.3. By Application

5.11. Key Representative Market Presence (Intensity Map)

6. Western Europe Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

6.3.1. U.K.

6.3.2. Germany

6.3.3. France

6.3.4. Italy

6.3.5. Spain

6.3.6. Nordics

6.3.7. BENELUX

6.3.8. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.4.1. U.K.

6.4.2. Germany

6.4.3. France

6.4.4. Italy

6.4.5. Spain

6.4.6. Nordics

6.4.7. BENELUX

6.4.8. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2016

6.5.1. Hyaluronic Acid Based Dermal Fillers

6.5.2. Non-hyaluronic Acid Based Dermal Fillers

6.5.3. Botulinum Toxin

6.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2017-2027

6.6.1. Hyaluronic Acid Based Dermal Fillers

6.6.2. Non-hyaluronic Acid Based Dermal Fillers

6.6.3. Botulinum Toxin

6.7. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

6.7.1. Aesthetic Volume Restoration

6.7.2. Wrinkle Reduction

6.8. Market Size (US$ Mn) Forecast, by Application, 2017-2027

6.8.1. Aesthetic Volume Restoration

6.8.2. Wrinkle Reduction

6.9. Drivers and Restraints: Impact Analysis

6.10. Market Attractiveness Analysis

6.10.1. By Country

6.10.2. By Product Type

6.10.3. By Application

6.11. Key Representative Market Presence (Intensity Map)

7. Eastern Europe Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country,2017-2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2016

7.5.1. Hyaluronic Acid Based Dermal Fillers

7.5.2. Non-hyaluronic Acid Based Dermal Fillers

7.5.3. Botulinum Toxin

7.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2017-2027

7.6.1. Hyaluronic Acid Based Dermal Fillers

7.6.2. Non-hyaluronic Acid Based Dermal Fillers

7.6.3. Botulinum Toxin

7.7. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

7.7.1. Aesthetic Volume Restoration

7.7.2. Wrinkle Reduction

7.8. Market Size (US$ Mn) Forecast, by Application, 2017-2027

7.8.1. Aesthetic Volume Restoration

7.8.2. Wrinkle Reduction

7.9. Drivers and Restraints: Impact Analysis

7.10. Market Attractiveness Analysis

7.10.1. By Country

7.10.2. By Product Type

7.10.3. By Application

7.11. Key Representative Market Presence (Intensity Map)

8. Asia-Pacific Excluding Japan (APEJ) Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

8.3.1. China

8.3.2. India

8.3.3. Australia and New Zealand

8.3.4. ASEAN

8.3.5. Rest of APEJ

8.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

8.4.1. China

8.4.2. India

8.4.3. Australia and New Zealand

8.4.4. ASEAN

8.4.5. Rest of APEJ

8.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2016

8.5.1. Hyaluronic Acid Based Dermal Fillers

8.5.2. Non-hyaluronic Acid Based Dermal Fillers

8.5.3. Botulinum Toxin

8.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2017-2027

8.6.1. Hyaluronic Acid Based Dermal Fillers

8.6.2. Non-hyaluronic Acid Based Dermal Fillers

8.6.3. Botulinum Toxin

8.7. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

8.7.1. Aesthetic Volume Restoration

8.7.2. Wrinkle Reduction

8.8. Market Size (US$ Mn) Forecast, by Application, 2017-2027

8.8.1. Aesthetic Volume Restoration

8.8.2. Wrinkle Reduction

8.9. Drivers and Restraints: Impact Analysis

8.10. Market Attractiveness Analysis

8.10.1. By Country

8.10.2. By Product Type

8.10.3. By Application

8.11. Key Representative Market Presence (Intensity Map)

9. Japan Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2016

9.2.1. Hyaluronic Acid Based Dermal Fillers

9.2.2. Non-hyaluronic Acid Based Dermal Fillers

9.2.3. Botulinum Toxin

9.3. Market Size (US$ Mn) and Volume Forecast By Product Type, 2017-2027

9.3.1. Hyaluronic Acid Based Dermal Fillers

9.3.2. Non-hyaluronic Acid Based Dermal Fillers

9.3.3. Botulinum Toxin

9.4. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

9.4.1. Aesthetic Volume Restoration

9.4.2. Wrinkle Reduction

9.5. Market Size (US$ Mn) Forecast, by Application, 2017-2027

9.5.1. Aesthetic Volume Restoration

9.5.2. Wrinkle Reduction

9.6. Drivers and Restraints: Impact Analysis

9.7. Market Attractiveness Analysis

9.7.1. By Product Type

9.7.2. By Application

9.8. Key Representative Market Presence (Intensity Map)

10. Middle East and Africa Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of MEA

10.4. Market Size (US$ Mn) Forecast By Country, 2017- 2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of MEA

10.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

10.5.1. Hyaluronic Acid Based Dermal Fillers

10.5.2. Non-hyaluronic Acid Based Dermal Fillers

10.5.3. Botulinum Toxin

10.6.Market Size (US$ Mn) Forecast By Product Type, 2017-2027

10.6.1. Hyaluronic Acid Based Dermal Fillers

10.6.2. Non-hyaluronic Acid Based Dermal Fillers

10.6.3. Botulinum Toxin

10.7.Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

10.7.1. Aesthetic Volume Restoration

10.7.2. Wrinkle Reduction

10.8.Market Size (US$ Mn) Forecast, by Application, 2017-2027

10.8.1. Aesthetic Volume Restoration

10.8.2. Wrinkle Reduction

10.9. Drivers and Restraints: Impact Analysis

10.10. Market Attractiveness Analysis

10.10.1. By Country

10.10.2. By Product Type

10.10.3. By Application

10.11. Key Representative Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Market Structure

13.2. Market Share Analysis

13.3. Competition Intensity Mapping By Market Taxonomy

13.4. Competition Dashboard

13.5. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments 

13.5.1. Allergan plc.

13.5.2. Galderma SA

13.5.3. Merz Pharma GmbH & Co. KGaA

13.5.4. Anika Therapeutics, Inc.

13.5.5. Suneva Medical, Inc.

13.5.6. Speciality European Pharma

13.5.7. HUGEL, Inc.

13.5.8. Grex Pharma SaS

13.5.9. Daewoong Pharmaceuticals

13.5.10. Medy-Tox Inc.

13.5.11. TEOXANE Laboratories

13.5.12. SciVision Biotech Inc.

14. Global Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027, By Region

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016

14.2.1. North America

14.2.2. Latin America

14.2.3. Western Europe

14.2.4. Eastern Europe

14.2.5. Asia Pacific Excluding Japan

14.2.6. Japan

14.2.7. Middle East and Africa

14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027

14.3.1. North America

14.3.2. Latin America

14.3.3. Western Europe

14.3.4. Eastern Europe

14.3.5. Asia Pacific Excluding Japan

14.3.6. Japan

14.3.7. Middle East and Africa

14.4. Market Attractiveness Analysis By Region

15. Global Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type

15.1. Introduction

15.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2016

15.2.1. Hyaluronic Acid Based Dermal Fillers

15.2.2. Non-hyaluronic Acid Based Dermal Fillers

15.2.3. Botulinum Toxin

15.3. Market Size (US$ Mn) and Volume Forecast By Product Type,2017-2027

15.3.1. Hyaluronic Acid Based Dermal Fillers

15.3.2. Non-hyaluronic Acid Based Dermal Fillers

15.3.3. Botulinum Toxin

15.4. Market Attractiveness Analysis by Product Type

16. Global Dermal Fillers and Botulinum Toxin Market Analysis 2012–2016 and Forecast 2017–2027, By Application

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis, by Application, 2012-2016

16.2.1. Aesthetic Volume Restoration

16.2.2. Wrinkle Reduction

16.3. Market Size (US$ Mn) Forecast, by Application, 2017-2027

16.3.1. Aesthetic Volume Restoration

16.3.2. Wrinkle Reduction

16.4. Market Attractiveness Analysis by Application 

17. Global Market Analysis 2012–2016 and Forecast 2017–2027

17.1. Market Size and Y-o-Y Growth

17.2. Absolute $ Opportunity

17.3. Value Chain

18. Assumptions and Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Dermal Fillers and Botulinum Toxin Market – Global FDA Dermal Fillers

Table 02: North America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 03: North America Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 04: North America Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 05: North America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 06: North America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 07: North America Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 08: Latin America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 09: Latin America Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 10: Latin America Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 11: Latin America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 12: Latin America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 13: Latin America Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 14: Western Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 15: Western Europe  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 16: Western Europe  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 17: Western Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 18: Western Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 19: Western Europe Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 20: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 21: Eastern Europe  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 22: Eastern Europe  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 23: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 24: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 25: Eastern Europe Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 26: APEJ  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 27: APEJ  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 28: APEJ  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 29: APEJ  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 30: APEJ  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 31: APEJ Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 32: Japan  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 33: Japan  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 34: Japan  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 35: Japan  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 36: Japan  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 37: Japan Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 38: MEA  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 39: MEA  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 40: MEA  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 41: MEA  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 42: MEA  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 43: MEA Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 44 Global Dermal Fillers and Botulinum Toxin Market: Intensity Mapping by Company

Table 45 Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 46 Global Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 47 Global Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 48 Global Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 49 Global Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: U.S FDA Regulatory Approval for Medical Devices

Figure 02: Europe Regulatory Approval for Medical Devices

Figure 03: U.S. FDA approved Dermal Fillers

Figure 04: North America Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 06: North America Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 05: North America Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 07: North America Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 08: North America Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 09: North America Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 10: U.S. Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 11: U.S. Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 12: Canada Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 13: Canada Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 14: North America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 15: North America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 16: North America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Country, 2017-2027

Figure 17: North America - Drivers & Restrains Impact Analysis

Figure 18: Latin America Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 19: Latin America Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 20: Latin America Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 21: Latin America Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 22: Latin America Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 23: Latin America Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 24: Brazil  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 25: Brazil Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 26: Mexico Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 27: Mexico Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 28: Argentina Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 29: Argentina Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 30: Rest of Latin America Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 31: Rest of Latin America Dermal Fillers and Botulinum Toxin Market Forecast, 2012 - 2016

Figure 32: Latin America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 33: Latin America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 34: Latin America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Country, 2017-2027

Figure 35: Latin America - Drivers & Restraint Impact Analysis

Figure 36: Western Europe  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 37: Western Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 38: Western Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 39: Western Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 40: Western Europe  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 41: Western Europe  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 42: U.K. Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 43: U.K. Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 44: Germany Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 45: Germany Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 46: France Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 47: France Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 48: Italy Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 49: Italy Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 50: Spain Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 51: Spain Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 52: Nordics Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 53: Nordics Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 54: Benelux Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 55: Benelux Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 56: Rest of Western Europe  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 57: Rest of Western Europe  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 58: Western Europe  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 59: Western Europe  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 60: Western Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 61: Western Europe - Drivers & Restraint Impact Analysis

Figure 62: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 63: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 64: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 65: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 66: Eastern Europe  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 67: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 68: Russia Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 69: Russia Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 70: Poland Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 71: Poland Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 72: Rest of Eastern Europe  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 73: Rest of Eastern Europe  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 74: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 75: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 76: Eastern Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 77: Eastern Europe - Drivers & Restraint Impact Analysis

Figure 78: APEJ  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 79: APEJ  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 80: APEJ  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 81: APEJ  Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 82: APEJ  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 83: APEJ  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 84: China Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 85: China Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 86: India Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 87: India Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 88: Australia and NZ Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 89: Australia and NZ Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 90: ASEAN Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 91: ASEAN Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 92: Rest of APEJ  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 93: Rest of APEJ  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 94: APEJ  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 95: APEJ  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 96: APEJ Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 97: APEJ - Drivers & Restraint Impact Analysis

Figure 98: Japan  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 99: Figure Japan  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 100: Japan  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 101: Japan  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 102: Japan  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 103: Japan  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 104: Japan  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 105: Japan- Drivers & Restraint Impact Analysis

Figure 106: MEA  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 108: MEA  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 107: MEA  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 109: MEA  Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 110: MEA  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 111: MEA  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 112: South Africa Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 113: South Africa Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 114: GCC Countries Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 115: GCC Countries Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 116: Rest of MEA  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 117: Rest of MEA  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 118: MEA  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 119: MEA  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 120: MEA Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 121: MEA Drivers & Restraint Impact Analysis

Figure 122 : Dermal Fillers and Botulinum Toxin Market Forecast Factors – Relevance and Impact

Figure 123: Global Dermal Fillers and Botulinum Toxin Market Share Analysis

Figure 124: Global Dermal Fillers Market Share Analysis

Figure 125: Global Botulinum Toxin Market Share Analysis

Figure 126: Global Bone Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) By Region, 2017 & 2027

Figure 127: Global Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Region, 2017-2027

Figure 128: Global Bone Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) By Product Type, 2017 & 2027

Figure 129: Global Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 130: Global Bone Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) By Application, 2017 & 2027

Figure 131: Global Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 132: Global Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 133: Global Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 134: Global Dermal Fillers and Botulinum Toxin Market Absolute $ Opportunity, 2012 - 2016

Figure 135: Global Dermal Fillers and Botulinum Toxin Market Absolute $ Opportunity, 2017 - 2027

Figure 136:  Global Dermal Fillers and Botulinum Toxin Market - Value Chain

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Dermal Fillers Market

Published : February 2021

Healthcare

Non-Hyaluronic Acid Dermal Filler Market

Published : October 2017

Google translate

Dermal Fillers and Botulinum Toxin Market